Legal Opinion
Rochester Drug Co-Operative, Inc. v. Braintree Laboratories
District Court, D. Delaware
Decided July 7, 2011No. Civ. 07-142-SLRPublishedCited by 1 opinion
1Opinion of the Court
MEMORANDUM OPINION
ROBINSON, District Judge.
I. INTRODUCTION
This is an antitrust action arising out of a patent infringement case filed on May 16, 2003 by Braintree Laboratories, Inc. (“Braintree”), a pharmaceutical company selling the constipation drug polyethylene glycol 3350 (“PEG”) in the United States under the brand name MiraLax®, against a generic drug manufacturer, Schwarz Pharma, Inc. (“Schwarz”), in which Brain-tree sought to preclude FDA approval for Schwarz’s generic PEG drug GlycoLax®. (Civ. No. 03-477-SLR (hereinafter, “the Braintree/Schwarz litigation”)) The Brain-tree/Schwarz…
2Cases cited11 opinions
- Ebay Inc. v. Mercexchange, L. L. C.Supreme Court of the United States · 2006
- United States v. Colgate & Co.Supreme Court of the United States · 1919
- Kos Pharmaceuticals, Inc. v. Andrx Corporation Andrx Laboratories, IncCourt of Appeals for the Third Circuit · 2004
- P.C. Yonkers, Inc. v. Celebrations the Party & Seasonal Superstore, LLCCourt of Appeals for the Third Circuit · 2005
- Mckeesport Hospital v. The Accreditation Council For Graduate Medical EducationCourt of Appeals for the Third Circuit · 1994
6 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- King Drug Co. of Florence, Inc. v. Cephalon, Inc.District Court, E.D. Pennsylvania · 2015